Metformin cream versus standard triple therapy for melasma
Part of Skin clinical trials.
This trial compares a cream containing metformin with a 3-part cream combination to see which is better at fading melasma, a common skin darkening condition. You would apply one of the creams daily and be monitored for improvement.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 50 years old
- You have been told you have a type of melasma called epidermal melasma (skin darkening, confirmed with a special lamp)
- You have not used any melasma treatment in the last month
- You have not had any skin resurfacing procedures (like laser or chemical peels) in the last 3 months
- You are able to give written consent to join
- You are not pregnant, and you do not have other skin conditions like acne or rosacea
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares a new cosmetic serum to a standard treatment (4% hydroquinone) for facial melasma over 84 days. It may help if you have mild to moderate melasma and are looking for a gentler alternative.
This study compares a 30% metformin cream to a standard combination cream (Kligman's regimen) for treating melasma in women. It aims to see which treatment works better at lightening dark patches and improving skin tone.
This trial tests whether a cream containing metformin or tranexamic acid can reduce melasma (dark patches on the face). It aims to see which treatment works better.
This trial tests whether a cream containing metformin or ketotifen can help lighten melasma patches on the face. Both creams are applied to the skin and compared against each other.
This trial tests two different triple-combination creams for melasma in women with skin types IV or V. Both creams contain a bleaching agent and a retinoid, but one uses a different steroid. The goal is to see which is safer and works better.
This trial tests a microneedling technique combined with three topical medications (metformin, tranexamic acid, and a modified Kligman's formula) to treat melasma, a common skin condition causing dark patches. The goal is to see if this approach safely and effectively reduces melasma in eligible women.
Hear when a new Epidermal Melasma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.